Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 21 Aug 2021 |
2 | Reply to Exam Report (MIS-R) | 18 Oct 2021 |
3 | Reply to Exam Report (MIS-R) | 30 Oct 2021 |
4 | TM-M(EXTENSION OF TIME) | 26 Dec 2023 |
5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 30 Jul 2024 |
6 | Journal Copy | 24 Aug 2024 |
1 | EXAMINATION REPORT | 12122667 | 07 Sep 2021 | |
2 | Hearing Notice (Show Cause) | 16683012 | 30 Nov 2023 | |
3 | Hearing Notice (Show Cause) | 18345078 | 19 Jun 2024 | |
4 | Tribunal Accepted Notice for : 5098543 | 18598260 | 6839430 | 30 Jul 2024 |
The application for Telmalyf was made on 21 August 2021.
The trademark applicant for Telmalyf is AKUMS DRUGS PHARMACEUTICALS.
Telmalyf is applied in class(es) 5.
Application for Telmalyf is on Opposed stage.
Application Id allotted to Telmalyf is 5098543.
Telmalyf filed with the Intellectual property office as a WORD.